These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31492939)

  • 21. Diversity of nucleotide sequences in hypervariable region 1 of hepatitis C virus in Japanese patients with chronic hepatitis C of unknown mode of transmission.
    Toyoda H; Fukuda Y; Hayakawa T; Kumada T; Nakano S; Takamatsu J; Saito H
    Dig Dis Sci; 1999 Oct; 44(10):1944-9. PubMed ID: 10548340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultradeep pyrosequencing of hepatitis C virus hypervariable region 1 in quasispecies analysis.
    Caraballo Cortés K; Zagordi O; Laskus T; Płoski R; Bukowska-Ośko I; Pawełczyk A; Berak H; Radkowski M
    Biomed Res Int; 2013; 2013():626083. PubMed ID: 23710455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of viral load and alanine aminotransferase on viral genetic heterogeneity in patients with chronic hepatitis C virus infection.
    Bozdayi AM; Uzunalimoglu O; Aslan N; Bozkaya H; Türkyilmaz AR; Kayhan B; Sahin T; Sivri B; Uygun A; Altiok A; Cetinkaya H; Karayalçin S; Yurdaydin C
    Intervirology; 2000; 43(1):61-6. PubMed ID: 10773739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes.
    Bukh J; Miller RH; Purcell RH
    Semin Liver Dis; 1995 Feb; 15(1):41-63. PubMed ID: 7597443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiregion deep sequencing of hepatitis C virus: An improved approach for genetic relatedness studies.
    Gonçalves Rossi LM; Escobar-Gutierrez A; Rahal P
    Infect Genet Evol; 2016 Mar; 38():138-145. PubMed ID: 26733442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamics of hypervariable region 1 variation in hepatitis C virus infection and correlation with clinical and virological features of liver disease.
    Brambilla S; Bellati G; Asti M; Lisa A; Candusso ME; D'Amico M; Grassi G; Giacca M; Franchini A; Bruno S; Ideo G; Mondelli MU; Silini EM
    Hepatology; 1998 Jun; 27(6):1678-86. PubMed ID: 9620342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
    Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Next-Generation Sequencing of Hepatitis C Virus (HCV) Mixed-Genotype Infections in Anti-HCV-Negative Blood Donors.
    Janiak M; Caraballo Cortés K; Perlejewski K; Kubicka-Russel D; Grabarczyk P; Demkow U; Radkowski M
    Adv Exp Med Biol; 2018; 1096():65-71. PubMed ID: 29594753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution of hepatitis C virus hypervariable region 1 in immunocompetent children born to HCV-infected mothers.
    Gismondi MI; Becker PD; Díaz Carrasco JM; Guzmán CA; Campos RH; Preciado MV
    J Viral Hepat; 2009 May; 16(5):332-9. PubMed ID: 19228286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Broadly reactive antibodies to hypervariable region 1 in hepatitis C virus-infected patient sera: relation to viral loads and response to interferon.
    Hattori M; Yoshioka K; Aiyama T; Iwata K; Terazawa Y; Ishigami M; Yano M; Kakumu S
    Hepatology; 1998 Jun; 27(6):1703-10. PubMed ID: 9620346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C Virus Escape Studies of Human Antibody AR3A Reveal a High Barrier to Resistance and Novel Insights on Viral Antibody Evasion Mechanisms.
    Velázquez-Moctezuma R; Galli A; Law M; Bukh J; Prentoe J
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody-free virion titer greatly differs between hepatitis C virus genotypes.
    Kimura Y; Hayashida K; Ishibashi H; Niho Y; Yanagi Y
    J Med Virol; 2000 May; 61(1):37-43. PubMed ID: 10745230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment.
    Zibert A; Schreier E; Roggendorf M
    Virology; 1995 Apr; 208(2):653-61. PubMed ID: 7538251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of hypervariable regions in the putative envelope protein of hepatitis C virus.
    Kato N; Ootsuyama Y; Ohkoshi S; Nakazawa T; Sekiya H; Hijikata M; Shimotohno K
    Biochem Biophys Res Commun; 1992 Nov; 189(1):119-27. PubMed ID: 1333186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection.
    Kato N; Ootsuyama Y; Sekiya H; Ohkoshi S; Nakazawa T; Hijikata M; Shimotohno K
    J Virol; 1994 Aug; 68(8):4776-84. PubMed ID: 7518526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1.
    Johnson J; Freedman H; Logan M; Wong JAJ; Hockman D; Chen C; He J; Beard MR; Eyre NS; Baumert TF; Tyrrell DL; Law JLM; Houghton M
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presence of different hepatitis C virus genotypes in plasma and peripheral blood mononuclear cell samples of Iranian patients with HIV infection.
    Dehghani-Dehej F; Sarvari J; Esghaei M; Hosseini SY; Garshasbi S; Kalantari S; Monavari SH; Fakhim A; Keyvani H; Bokharaei-Salim F
    J Med Virol; 2018 Aug; 90(8):1343-1351. PubMed ID: 28845894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokine profile and viral diversity in the early seronegative stage of community-acquired hepatitis C virus (HCV) infection.
    Radkowski M; Grabarczyk P; Kryczka T; Caraballo Cortès K; Kubicka-Russel D; Janiak M; Osuch S; Perlejewski K; Laskus T
    Sci Rep; 2023 Nov; 13(1):20045. PubMed ID: 37973814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b infection [correction of interferon].
    López-Labrador FX; Ampurdanès S; Giménez-Barcons M; Guilera M; Costa J; Jiménez de Anta MT; Sánchez-Tapias JM; Rodés J; Sáiz JC
    Hepatology; 1999 Mar; 29(3):897-903. PubMed ID: 10051495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution of the hepatitis C virus second envelope protein hypervariable region in chronically infected patients receiving alpha interferon therapy.
    Pawlotsky JM; Germanidis G; Frainais PO; Bouvier M; Soulier A; Pellerin M; Dhumeaux D
    J Virol; 1999 Aug; 73(8):6490-9. PubMed ID: 10400744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.